Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE

Rang in Aktien #667
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Aktienkurs
$19.12
Marktkapitalisierung
$36.72B
Veränderung (1 Tag)
1.30%
Veränderung (1 Jahr)
27.77%
Land
US
Handel Kenvue Inc. (KVUE)

Kategorie

Consumer Defensive
Dividendenrendite-Verlauf für Kenvue Inc. (KVUE)
Dividendenrendite (TTM) von Kenvue Inc. (Aktienkürzel: KVUE) zum 2023-12-31: 36.56%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 8.08%
Dividendenrendite-Verlauf für Kenvue Inc. (KVUE) von 2019 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
2026 (TTM) 5.79% 51.17%
2024 3.83% -89.52%
2023 36.56% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber